Clinical features of migraine with aura: a REFORM study.

"Declarations Ethics approval and consent to participateThe study protocol received approval from the Health Research Ethics Committee of the Capital Region of Denmark, and all participants provided written informed consent before undergoing any study-related assessments or procedures. Consent for publicationNot applicable. Competing interestsH.A. reports personal fees from Lundbeck and Teva, outside of the submitted work. H.M.A. reports personal fees from Pfizer, outside of the submitted work. F.M.A. reports personal fees from Eli Lilly, Lundbeck, Novartis, Teva, and Pfizer, outside of the submitted work. F.M.A. also serves on the editorial board of Cephalalgia, Cephalalgia Reports, Frontiers in Neurology, Frontiers in Pain Research, Headache Medicine, and The Journal of Headache and Pain. M.A. reports personal fees from AbbVie, Amgen, Eli Lilly, GlaxoSmithKline, Lundbeck, Novartis, Pfizer, and Teva, outside of the submitted work. M.A. also serves on the editorial board of Brain, Cephalalgia, and The Journal of Headache and Pain. A.V.T., K.R., and R.H.C. report no potential conflicts of interest. Competing interests H.A. reports personal fees from Lundbeck and Teva, outside of the submitted work. H.M.A. reports personal fees from Pfizer, outside of the submitted work. F.M.A. reports personal fees from Eli Lilly, Lundbeck, Novartis, Teva, and Pfizer, outside of the submitted work. F.M.A. also serves on the editorial board of Cephalalgia, Cephalalgia Reports, Frontiers in Neurology, Frontiers in Pain Research, Headache Medicine, and The Journal of Headache and Pain. M.A. reports personal fees from AbbVie, Amgen, Eli Lilly, GlaxoSmithKline, Lundbeck, Novartis, Pfizer, and Teva, outside of the submitted work. M.A. also serves on the editorial board of Brain, Cephalalgia, and The Journal of Headache and Pain. A.V.T., K.R., and R.H.C. report no potential conflicts of interest."

"Funding M.A. was supported by the Lundbeck Foundation professor grant (R310-2018–3711)."